CLNN
CLNN
NASDAQ · Biotechnology

Clene Inc

$4.06
-0.24 (-5.58%)
As of Sep 28, 10:29 PM ET ·
Financial Highlights (FY 2026)
Revenue
288.5K
Net Income
-37,735,277
Gross Margin
78.5%
Profit Margin
-13,086.5%
Rev Growth
-24.8%
D/E Ratio
1.99
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.5% 78.5% 37.4% 37.4%
Operating Margin -11,541.5% -10,387.4% 12.4% 13.7%
Profit Margin -13,086.5% -12,432.2% 8.8% 10.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 288.5K 383.6K 28.89M 22.68M
Gross Profit 226.5K 301.1K 10.80M 8.48M
Operating Income -33,302,190 -39,845,747 3.57M 3.11M
Net Income -37,735,277 -45,149,892 2.55M 2.38M
Gross Margin 78.5% 78.5% 37.4% 37.4%
Operating Margin -11,541.5% -10,387.4% 12.4% 13.7%
Profit Margin -13,086.5% -12,432.2% 8.8% 10.5%
Rev Growth -24.8% -24.8% +0.1% +7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 20.35M 20.35M 25.17M 22.41M
Total Equity 10.21M 10.21M 35.16M 34.69M
D/E Ratio 1.99 1.99 0.72 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -31,124,355 -39,308,876 4.88M 3.72M
Free Cash Flow — — 2.44M 2.81M